Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

71,347 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Early T-Cell Precursor Acute Lymphoblastic Leukemia and T/Myeloid Mixed Phenotype Acute Leukemia Possess Overlapping Characteristics and Both Benefit From CAG-Like Regimens and Allogeneic Hematopoietic Stem Cell Transplantation.
Liu S, Cui Q, Dai H, Song B, Cui W, Xue S, Qiu H, Miao M, Jin Z, Li C, Fu C, Wang Y, Sun A, Chen S, Zhu X, Wu D, Tang X. Liu S, et al. Transplant Cell Ther. 2021 Jun;27(6):481.e1-481.e7. doi: 10.1016/j.jtct.2021.02.032. Epub 2021 Feb 28. Transplant Cell Ther. 2021. PMID: 33785365 Free article.
Case report: CD38-directed CAR-T cell therapy: A novel immunotherapy targeting CD38- positive blasts overcomes TKI and chemotherapy resistance of myeloid chronic myeloid leukemia in blastic phase.
Cui Q, Liang P, Dai H, Cui W, Cai M, Ding Z, Ma Q, Yin J, Li Z, Liu S, Kang L, Yao L, Cen J, Shen H, Zhu M, Yu L, Wu D, Tang X. Cui Q, et al. Among authors: liu s. Front Immunol. 2022 Nov 29;13:1012981. doi: 10.3389/fimmu.2022.1012981. eCollection 2022. Front Immunol. 2022. PMID: 36524116 Free PMC article.
Decitabine in combination with fludarabine and cyclophosphamide as a lymphodepletion regimen followed by CD19/CD22 bispecific targeted CAR T-cell therapy significantly improves survival in relapsed/refractory B-ALL patients.
Ma Y, Dai H, Cui Q, Liu S, Kang L, Lian X, Cui W, Yin J, Liu L, Cai M, Yu L, Wu D, Tang X. Ma Y, et al. Among authors: liu l, liu s. Exp Hematol Oncol. 2023 Apr 10;12(1):36. doi: 10.1186/s40164-023-00397-z. Exp Hematol Oncol. 2023. PMID: 37038230 Free PMC article.
Efficacy and safety of mesenchymal stem cells treatment for multidrug-resistant graft-versus-host disease after haploidentical allogeneic hematopoietic stem cell transplantation.
Shen MZ, Liu XX, Qiu ZY, Xu LP, Zhang XH, Wang Y, Yan CH, Chen H, Chen YH, Han W, Wang FR, Wang JZ, Liu SN, Liu KY, Huang XJ, Mo XD. Shen MZ, et al. Ther Adv Hematol. 2022 Jan 20;13:20406207211072838. doi: 10.1177/20406207211072838. eCollection 2022. Ther Adv Hematol. 2022. PMID: 35096361 Free PMC article.
71,347 results
You have reached the last available page of results. Please see the User Guide for more information.